Published in Q J Nucl Med Mol Imaging on March 01, 2007
Radiopharmaceutical development of radiolabelled peptides. Eur J Nucl Med Mol Imaging (2012) 1.34
Radiolabeled peptides: valuable tools for the detection and treatment of cancer. Theranostics (2012) 1.33
Radiolabelled peptides for oncological diagnosis. Eur J Nucl Med Mol Imaging (2012) 0.93
Bombesin receptor-mediated imaging and cytotoxicity: review and current status. Curr Drug Deliv (2011) 0.93
Non-invasive molecular imaging for preclinical cancer therapeutic development. Br J Pharmacol (2013) 0.91
Synthesis, Characterization, and Interaction with Biomolecules of Platinum(II) Complexes with Shikimic Acid-Based Ligands. Bioinorg Chem Appl (2013) 0.80
Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumors. EJNMMI Res (2016) 0.77
Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting. Nucl Med Biol (2015) 0.75
TIF4631 and TIF4632: two yeast genes encoding the high-molecular-weight subunits of the cap-binding protein complex (eukaryotic initiation factor 4F) contain an RNA recognition motif-like sequence and carry out an essential function. Mol Cell Biol (1993) 3.85
Decoying the cap- mRNA degradation system by a double-stranded RNA virus and poly(A)- mRNA surveillance by a yeast antiviral system. Mol Cell Biol (1995) 2.17
Stable one-step technetium-99m labeling of His-tagged recombinant proteins with a novel Tc(I)-carbonyl complex. Nat Biotechnol (1999) 2.03
Influence of the denticity of ligand systems on the in vitro and in vivo behavior of (99m)Tc(I)-tricarbonyl complexes: a hint for the future functionalization of biomolecules. Bioconjug Chem (2000) 1.60
Peptide linkers lead to modification of liver metabolism and improved tumor targeting of copper-67-labeled antibody fragments. Cancer Biother Radiopharm (2001) 1.51
The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur J Pharmacol (1994) 1.43
Biosynthesis of the lantibiotic Pep5. Isolation and characterization of a prepeptide containing dehydroamino acids. Eur J Biochem (1990) 1.40
Action of derivatives of mu-conotoxin GIIIA on sodium channels. Single amino acid substitutions in the toxin separately affect association and dissociation rates. Biochemistry (1992) 1.39
The clinical spectrum of band erosion following laparoscopic adjustable silicone gastric banding for morbid obesity. Surg Endosc (2003) 1.35
High thermal stability is essential for tumor targeting of antibody fragments: engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. Cancer Res (1999) 1.32
ESAG 6 and 7 products of Trypanosoma brucei form a transferrin binding protein complex. Eur J Cell Biol (1994) 1.25
Organometallic 99mTc-aquaion labels peptide to an unprecedented high specific activity. J Nucl Med (1999) 1.16
Palmitoylation alters protein activity: blockade of G(o) stimulation by GAP-43. EMBO J (1992) 1.13
Derivatives of 1,3,5-triamino-1,3,5-trideoxy-cis-inositol as versatile pentadentate ligands for protein labeling with Re-186/188. prelabeling, biodistribution, and X-ray structural studies. Bioconjug Chem (1999) 1.12
Elliptic flow of charged particles in Pb-Pb collisions at sqrt[S(NN)] = 2.76 TeV. Phys Rev Lett (2010) 1.12
A fast and inexpensive method for N-terminal fluorescein-labeling of peptides. Bioorg Med Chem Lett (1998) 1.07
Molecular characterization of the ligand-receptor interaction of the neuropeptide Y family. J Pept Sci (2000) 1.07
Structure and dynamics of micelle-bound neuropeptide Y: comparison with unligated NPY and implications for receptor selection. J Mol Biol (2001) 1.06
From micromolar to nanomolar affinity: a systematic approach to identify the binding site of CGRP at the human calcitonin gene-related peptide 1 receptor. J Med Chem (1998) 1.03
Epitope mapping of the Dermatophagoides pteronyssinus house dust mite major allergen Der p II using overlapping synthetic peptides. Mol Immunol (1991) 1.03
Band slippage after laparoscopic adjustable gastric banding: etiology and treatment. Surg Endosc (2004) 1.03
Novel peptide conjugates for tumor-specific chemotherapy. J Med Chem (2001) 1.02
Central vaspin administration acutely reduces food intake and has sustained blood glucose-lowering effects. Diabetologia (2011) 1.02
Autoaggressive myocytotoxic T lymphocytes expressing an unusual gamma/delta T cell receptor. J Exp Med (1992) 1.01
Comparison of the photochemical behavior of four different photoactivatable probes. J Pept Res (1997) 1.00
The first selective agonist for the neuropeptide YY5 receptor increases food intake in rats. J Biol Chem (2000) 1.00
Monitoring of the internalization of neuropeptide Y on neuroblastoma cell line SK-N-MC. Eur J Biochem (2000) 0.99
A novel splice variant of a metabotropic glutamate receptor, human mGluR7b. Neuropharmacology (1997) 0.98
Tumor targeting of mono-, di-, and tetravalent anti-p185(HER-2) miniantibodies multimerized by self-associating peptides. J Biol Chem (2001) 0.98
Binding site for IgE of the human lymphocyte low-affinity Fc epsilon receptor (Fc epsilon RII/CD23) is confined to the domain homologous with animal lectins. Proc Natl Acad Sci U S A (1989) 0.98
[Acute and transitory intracranial hypertension in a 9-year-old child treated by nalidixic acid]. Arch Fr Pediatr (1972) 0.97
Chemical and biological characterization of technetium(I) and Rhenium(I) tricarbonyl complexes with dithioether ligands serving as linkers for coupling the Tc(CO)(3) and Re(CO)(3) moieties to biologically active molecules. Bioconjug Chem (2000) 0.96
Peptides as carrier for tumor diagnosis and treatment. Curr Med Chem Anticancer Agents (2001) 0.96
Biosynthesis of peptide hormones derived from precursor sequences. Curr Med Chem (2004) 0.96
Immune recovery after fludarabine-cyclophosphamide-rituximab treatment in B-chronic lymphocytic leukemia: implication for maintenance immunotherapy. Leukemia (2010) 0.96
Production and separation of ''non-standard'' PET nuclides at a large cyclotron facility: the experiences at the Paul Scherrer Institute in Switzerland. Q J Nucl Med Mol Imaging (2008) 0.95
Fluorimetric analysis of the binding of warfarin to human serum albumin. Equilibrium and kinetic study. Mol Pharmacol (1982) 0.93
Centrality dependence of the charged-particle multiplicity density at midrapidity in Pb-Pb collisions at sqrt[s(NN)] = 2.76 TeV. Phys Rev Lett (2011) 0.93
Role of prohormone convertases in pro-neuropeptide Y processing: coexpression and in vitro kinetic investigations. Biochemistry (1997) 0.93
Begging calls support offspring individual identity and recognition by zebra finch parents. C R Biol (2009) 0.93
Cytological detection of spermatozoa: comparison of three staining methods. J Forensic Sci (2001) 0.93
Immunoglobulin E-binding site in Fc epsilon receptor (Fc epsilon RII/CD23) identified by homolog-scanning mutagenesis. J Biol Chem (1992) 0.92
[Left paramedian thalamic infarct. Memory and language study]. Rev Neurol (Paris) (1982) 0.91
Comparison of [18F]-tracers in various experimental tumor models by PET imaging and identification of an early response biomarker for the novel microtubule stabilizer patupilone. Mol Imaging Biol (2009) 0.91
Relevance relations for the concept of reproducibility. J R Soc Interface (2014) 0.90
The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C. Cancer Res (2001) 0.90
Dicarbonyl-nitrosyl-complexes of rhenium (Re) and technetium (Tc), a potentially new class of compounds for the direct radiolabeling of biomolecules. Cancer Biother Radiopharm (2001) 0.90
PYY3-36 as an anti-obesity drug target. Obes Rev (2005) 0.90
Synthetic S-(2,3-dihydroxypropyl)-cysteinyl peptides derived from the N-terminus of the cytochrome subunit of the photoreaction centre of Rhodopseudomonas viridis enhance murine splenocyte proliferation. J Pept Sci (1997) 0.89
Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal anti-granulocytes antibodies. Nucl Med Commun (1986) 0.89
Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor. Mol Pharmacol (1996) 0.88
Developmental changes of agonist affinity at GABABR1 receptor variants in rat brain. Mol Cell Neurosci (1998) 0.88
Differential cellular localization of three splice variants of the mGluR1 metabotropic glutamate receptor in rat cerebellum. Neuroreport (1994) 0.88
Targeting superficial bladder cancer by the intravesical administration of copper-67-labeled anti-MUC1 mucin monoclonal antibody C595. J Clin Oncol (2000) 0.87
Novel analogues of neuropeptide Y with a preference for the Y1-receptor. Eur J Biochem (2001) 0.87
Midrapidity antiproton-to-proton ratio in pp collisons at sqrt[s]=0.9 and 7 TeV measured by the ALICE experiment. Phys Rev Lett (2010) 0.87
Radiometal targeted tumor diagnosis and therapy with peptide hormones. Curr Pharm Des (2008) 0.87
A 99mTc(I)-postlabeled high affinity bombesin analogue as a potential tumor imaging agent. Bioconjug Chem (2002) 0.86
Antibodies to the protein core of the small cell lung cancer workshop antigen cluster-w4 and to the leucocyte workshop antigen CD24 recognize the same short protein sequence leucine-alanine-proline. Clin Exp Immunol (1993) 0.85
Neuropeptide Y(5) receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices. J Neurophysiol (2000) 0.85
A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients. Eur J Nucl Med (2001) 0.84
Optical studies into the nature of the high affinity binding site of human serum albumin for phenylbutazone. Mol Pharmacol (1979) 0.84
Anti-neuroblastoma antibody chCE7 binds to an isoform of L1-CAM present in renal carcinoma cells. Int J Cancer (1999) 0.84
Molecular cloning, functional expression and pharmacological characterization of the human metabotropic glutamate receptor type 4. Neuropharmacology (1995) 0.84
Catalytic enantioselective synthesis of 18F-fluorinated alpha-amino acids under phase-transfer conditions using (S)-NOBIN. Nucl Med Biol (2004) 0.84
Development of a rapid and sensitive method for the quantitation of benzodiazepines in Calliphora vicina larvae and puparia by LC-MS-MS. J Anal Toxicol (2003) 0.84
Pharmacokinetics of vancomycin in patients undergoing haemodialysis and haemofiltration. Nephrol Dial Transplant (1989) 0.83
Immunocytochemical localization of angiotensin II receptor subtypes and angiotensin II with monoclonal antibodies in the rat adrenal gland. Regul Pept (2001) 0.83
Development of a simple and selective separation of 67Cu from irradiated zinc for use in antibody labelling: a comparison of methods. Appl Radiat Isot (1995) 0.83
Preclinical evaluation of copper-67 labelled anti-MUC1 mucin antibody C595 for therapeutic use in bladder cancer. Eur J Nucl Med (1997) 0.83
Electrophysiological study, biodistribution in mice, and preliminary PET evaluation in a rhesus monkey of 1-amino-3-[18F]fluoromethyl-5-methyl-adamantane (18F-MEM): a potential radioligand for mapping the NMDA-receptor complex. Nucl Med Biol (1998) 0.83
Radiosynthesis of [11C]brofaromine, a potential tracer for imaging monoamine oxidase A. Nucl Med Biol (1996) 0.82
99mTc-labeled neuropeptide Y analogues as potential tumor imaging agents. Bioconjug Chem (2001) 0.82
Cellular and subcellular localization of the mGluR5a metabotropic glutamate receptor in rat spinal cord. Neuroreport (1994) 0.82
On the role of thymopoietins in cell proliferation. Immunochemical evidence for new members of the human thymopoietin family. Biol Chem (1999) 0.82
Prisoners and skin diseases in Toulouse, France: epidemiological analysis and evaluation of life impact. J Eur Acad Dermatol Venereol (2008) 0.82
CGRP 27-37 analogues with high affinity to the CGRP1 receptor show antagonistic properties in a rat blood flow assay. Regul Pept (1999) 0.81
Prophylactic diclofenac infusions in major orthopedic surgery: effects on analgesia and acute phase proteins. Acta Anaesthesiol Scand (1992) 0.81
Chemical modification of epibatidine causes a switch from agonist to antagonist and modifies its selectivity for neuronal nicotinic acetylcholine receptors. Chem Biol (2000) 0.81
Derivatization of glucose and 2-deoxyglucose for transition metal complexation: substitution reactions with organometallic 99mTc and Re precursors and fundamental NMR investigations. Chemistry (2001) 0.81
Amoxycillin metabolism studied by combination of HPLC and spectrophotometry on urinary samples. Arch Int Pharmacodyn Ther (1982) 0.81
A rational approach for the development of reduced-size analogues of neuropeptide Y with high affinity to the Y1 receptor. J Pept Sci (1997) 0.81
Exposure to antimony from polyethylene terephthalate (PET) trays used in ready-to-eat meals. Food Addit Contam (2007) 0.81
Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y: evidence for subtype-differentiating effects on affinity and intrinsic efficacy. Mol Pharmacol (1992) 0.81
Y-receptor affinity modulation by the design of pancreatic polypeptide/neuropeptide Y chimera led to Y(5)-receptor ligands with picomolar affinity. Peptides (2001) 0.81
Cloning and functional expression of the guinea pig neuropeptide Y Y2 receptor. Regul Pept (1998) 0.81
Synthesis, radiolabelling and biological characterization of (D)-7-iodo-N-(1-phosphonoethyl)-5-aminomethylquinoxaline-2,3-dione, a glycine-binding site antagonist of NMDA receptors. Bioorg Med Chem Lett (2000) 0.81
The usefulness of post-mortem CT angiography in injuries caused by falling from considerable heights: three fatal cases. Diagn Interv Imaging (2014) 0.81
Differently labeled peptide ligands for rapid investigation of receptor expression on a new human glioblastoma cell line. Peptides (2000) 0.80
Probing of the neuropeptide Y-Y1-receptors interaction with anti-receptor antibodies. Eur J Biochem (1998) 0.80
Y1 receptors in the nucleus accumbens: ultrastructural localization and association with neuropeptide Y. J Neurosci Res (1998) 0.80
Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma. Cancer Biother Radiopharm (2001) 0.80
Molecular characterization of the ligand-receptor interaction of neuropeptide Y. Curr Med Chem (1999) 0.80
A triglycine linker improves tumor uptake and biodistributions of 67-Cu-labeled anti-neuroblastoma MAb chCE7 F(ab')2 fragments. Nucl Med Biol (1999) 0.80
Molecular cloning, functional expression and pharmacological characterization of the human metabotropic glutamate receptor type 2. Eur J Neurosci (1995) 0.80